The Research Associates team at Switch Therapeutics plays a vital role in advancing the company's pioneering CASi platform by conducting experiments and analyses across various scientific disciplines, including biology and chemistry. They support the development and optimization of nucleic acid nanotechnology and RNA interference solutions, collaborating closely with senior researchers to innovate and refine therapeutic approaches targeting diseases with significant unmet medical needs. Their work is integral to exploring the efficacy and safety of new drug candidates and facilitating the progression from laboratory research to clinical applications.
View all